Mechanistically, RKIP could upregulate miR-450b-5p, which is downregulated and can directly target NRF2 in NPC, subsequently suppress the activity of NRF2/NQO1 axis, and eventually improve the radiosensitivity of NPC cells. The gene discussed is PEBP1; the disease is nasopharyngeal carcinoma.